| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 55.08 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Pathological complete response (pCR) to neoadjuvant chemotherapy (NAChT) has been validated as a predictor of long-term survival in breast cancer (BC), especially in triple-negative breast cancer (TNBC)
Descrição
Palavras-chave
Contexto Educativo
Citação
Editora
Elsevier
